The Vancouver Sun on MSN
B.C. mulls funding drug for patients with genetic cholesterol disorder who can't tolerate statins
B.C. is reviewing whether to fund an expensive drug for patients who have a genetic condition that causes dangerously high ...
Sweetpotato farmers may soon have higher yields of the root crop after University of the Philippines Los Baños (UPLB) ...
Ten of the twelve former Food and Drug Administration (FDA) commissioners and acting commissioners opposed to the Trump ...
Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...
Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseasesQfitlia, the first antithrombin-lowering therapy for hemophilia, ...
China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura: Paris Friday, December 12, 2025, 09:00 Hrs [IST] The National ...
Bangladesh is once again in the grip of a severe dengue and chikungunya crisis in 2025. Hospitals are overwhelmed, fever ...
Candidates preparing for JEE Advanced 2026 can download the official syllabus PDF from jeeadv.ac.in, released by IIT Roorkee.
Two government officials told STAT that the White House has been involved in final decisions about the FDA's new priority ...
News-Medical.Net on MSN
SARS-CoV-2 manipulates host cell's RNA to weaken the immune response
Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes COVID-19, uses a sophisticated tactic to evade the human body's defense ...
Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% ...
During this symposium, leading international epileptologists discussed the key challenges and opportunities that currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results